Latest Updates
Freeline Therapeutics Gene Therapy
Gene Therapy for Hemophilia B can replace lifelong need for factor IX injections
Freeline Therapeutics has advanced a new gene therapy that can potentially replace the need for lifelong factor IX injections in patients with Hemophilia B. This
July 28, 2022
monkeypok in india
Monkeypox is not new, but the pattern of outbreak is new and unprecedented
The first human case of Monkeypox can be dated back to 1970. Democratic Republic of Congo was the first country to report Monkeypox in humans
May 31, 2022
DNA synthesis technology by Evonetix
New Patent granted for Thermally-controlled DNA synthesis technology by Evonetix
Evonetix Ltd has completed yet another milestone in its pursuit of reimagining biology with proprietary DNA synthesis technologies. The company’s thermally controlled technology for DNA
April 7, 2022
mCRPC management
Novartis’s Pluvicto (radioligand therapy) is now FDA Approved for mCRPC treatment
The Swiss based Pharma Major scores yet another FDA approval for its new radioligand therapy. This much anticipated regulatory nod was received this week, enabling
March 26, 2022
Genetic Sequencing and Gene Therapy
Nanopore DNA sequencing – New genetic test to diagnose Rare Neurological Diseases
Diagnosing some of the rare or hidden neurological disorders has been a challenge to the medical fraternity for long. Several conditions are often presented with
March 20, 2022
Allogene
How is it looking for CAR-T and Gene Therapies so far in 2022?
With almost a quarter gone by in 2022, it would be a natural tendency for the Gene Therapy enthusiasts and market observers to try and
March 12, 2022
Popular Posts
Why Remdesivir is so much on demand for COVID Patients in India?
May 3, 2021
No Comments
The COVID crisis is consuming thousands of Indians every day. There is panic and sense of helplessness everywhere. Amidst all this, there is never ending
AstraZeneca’s Tezepelumab found to significantly reduce Asthma Exacerbations
July 15, 2021
No Comments
One of the global Biopharma Majors, AstraZeneca has recently announced that their Biologics License Application (BLA) for Tezepelumab has been granted Priority Review by the
Biosimilar Drugs – Improved Access and Health Economics with New Age Adaptations
June 7, 2021
No Comments
What are Biosimilar Drugs? Filgrastim-sndz was the first Biosimilar to be approved by the US FDA in 2015. There has been active participation by the
Gene Therapy for Hemophilia B can replace lifelong need for factor IX injections
July 28, 2022
No Comments
Freeline Therapeutics has advanced a new gene therapy that can potentially replace the need for lifelong factor IX injections in patients with Hemophilia B. This